Literature DB >> 17513973

Decreased bone mineral density in neurofibromatosis type 1: results from a pediatric cohort.

Sukhdeep Dulai1, Julie Briody, Aaron Schindeler, Kathryn N North, Christopher T Cowell, David G Little.   

Abstract

Neurofibromatosis type 1 (NF1) is a common genetic disorder affecting 1 in 3000 live births. It is well documented to be associated with bony deformities and other orthopaedic problems. Based on our observation that NF1 patients undergoing orthopaedic surgery often had osteopenic bone, we performed a study to assess the bone mineral density of a cohort of children with NF1 without orthopaedic defects.Twenty-three patients were recruited from the neurofibromatosis clinic. The bone mineral density of the total body, lumbar spine, and proximal femur was measured using dual-energy x-ray absorptiometry. Quantitative ultrasound was used to measure broadband ultrasonic attenuation at both heels. The group's mean dual-energy x-ray absorptiometry sex- and age-matched Z scores were below normal (-0.8 +/- 1.1, -0.8 +/- 1.2, -0.7 +/- 0.8, -0.6 +/- 1.1, -0.6 +/- 0.9, -0.6 +/- 1.1 for the total body, arms, legs, lumbar spine, and right and left femoral neck, respectively; all P < 0.01). Although some individuals had normal bone mass, 30% had total body Z scores below -1.5. The mean heel broadband ultrasonic attenuation Z score was also lower than normal (-0.8 +/- 0.6; P < 0.001). Children with NF1 have a general tendency toward osteopenia, suggesting an abnormal underlying bone phenotype. This may be relevant when considering operative intervention and, if better understood, may partially explain poor bone healing associated with NF1.

Entities:  

Mesh:

Year:  2007        PMID: 17513973     DOI: 10.1097/01.bpb.0000271310.87997.ae

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  21 in total

1.  Bone resorption in syndromes of the Ras/MAPK pathway.

Authors:  D A Stevenson; E L Schwarz; J C Carey; D H Viskochil; H Hanson; S Bauer; H-Y Cindy Weng; T Greene; K Reinker; J Swensen; R J Chan; F-C Yang; L Senbanjo; Z Yang; R Mao; M Pasquali
Journal:  Clin Genet       Date:  2011-01-19       Impact factor: 4.438

2.  Pediatric 25-hydroxyvitamin D concentrations in neurofibromatosis type 1.

Authors:  David A Stevenson; David H Viskochil; John C Carey; Xiaoming Sheng; Mary Murray; Laurie Moyer-Mileur; Judd Shelton; William L Roberts; Ashley M Bunker; Heather Hanson; Stephanie Bauer; Jacques L D'Astous
Journal:  J Pediatr Endocrinol Metab       Date:  2011       Impact factor: 1.634

3.  Bone Status According to Neurofibromatosis Type 1 Phenotype: A Descriptive Study of 60 Women in France.

Authors:  Maud Jalabert; Salah Ferkal; Jean-Claude Souberbielle; Emilie Sbidian; Arthur Mageau; Florent Eymard; Philippe Le Corvoisier; Laurence Allanore; Xavier Chevalier; Pierre Wolkenstein; Sandra Guignard
Journal:  Calcif Tissue Int       Date:  2021-02-08       Impact factor: 4.333

4.  Decreased bone mineralization in children with Noonan syndrome: another consequence of dysregulated RAS MAPKinase pathway?

Authors:  Kiran S Choudhry; Monica Grover; Alyssa A Tran; E O'Brian Smith; Kenneth J Ellis; Brendan H Lee
Journal:  Mol Genet Metab       Date:  2012-04-11       Impact factor: 4.797

5.  Multiple increased osteoclast functions in individuals with neurofibromatosis type 1.

Authors:  David A Stevenson; Jincheng Yan; Yongzheng He; Huijie Li; Yaling Liu; Qi Zhang; Yongmin Jing; Zhiping Guo; Wei Zhang; Dalong Yang; Xiaohua Wu; Heather Hanson; Xiaohong Li; Karl Staser; David H Viskochil; John C Carey; Shi Chen; Lucy Miller; Kent Roberson; Laurie Moyer-Mileur; Menggang Yu; Elisabeth L Schwarz; Marzia Pasquali; Feng-Chun Yang
Journal:  Am J Med Genet A       Date:  2011-04-04       Impact factor: 2.802

6.  Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis.

Authors:  Steven D Rhodes; Hao Yang; Ruizhi Dong; Keshav Menon; Yongzheng He; Zhaomin Li; Shi Chen; Karl W Staser; Li Jiang; Xiaohua Wu; Xianlin Yang; Xianghong Peng; Khalid S Mohammad; Theresa A Guise; Mingjiang Xu; Feng-Chun Yang
Journal:  J Bone Miner Res       Date:  2015-05-21       Impact factor: 6.741

7.  Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.

Authors:  Steven D Rhodes; Xiaohua Wu; Yongzheng He; Shi Chen; Hao Yang; Karl W Staser; Jiapeng Wang; Ping Zhang; Chang Jiang; Hiroki Yokota; Ruizhi Dong; Xianghong Peng; Xianlin Yang; Sreemala Murthy; Mohamad Azhar; Khalid S Mohammad; Mingjiang Xu; Theresa A Guise; Feng-Chun Yang
Journal:  J Bone Miner Res       Date:  2013-12       Impact factor: 6.741

Review 8.  Aberrant Myeloid Differentiation Contributes to the Development of Osteoporosis in Neurofibromatosis Type 1.

Authors:  Steven D Rhodes; Feng-Chun Yang
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

9.  Tibial geometry in individuals with neurofibromatosis type 1 without anterolateral bowing of the lower leg using peripheral quantitative computed tomography.

Authors:  David A Stevenson; David H Viskochil; John C Carey; Hillarie Slater; Mary Murray; Xiaoming Sheng; Jacques D'Astous; Heather Hanson; Elizabeth Schorry; Laurie J Moyer-Mileur
Journal:  Bone       Date:  2008-12-11       Impact factor: 4.398

10.  Evidence of increased bone resorption in neurofibromatosis type 1 using urinary pyridinium crosslink analysis.

Authors:  David A Stevenson; Elisabeth L Schwarz; David H Viskochil; Laurie J Moyer-Mileur; Mary Murray; Sean D Firth; Jacques L D'Astous; John C Carey; Marzia Pasquali
Journal:  Pediatr Res       Date:  2008-06       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.